4.1 Article

Collective invasion of carcinoma cells When the fibroblasts take the lead

期刊

CELL ADHESION & MIGRATION
卷 2, 期 1, 页码 45-47

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/cam.2.1.5705

关键词

collective invasion; carcinoma associated fibroblast; extracellular matrix; matrix metalloproteinases; Rho

资金

  1. Cancer Research UK
  2. Bettencourt-Schueller Fondation

向作者/读者索取更多资源

Epithelial to mesenchymal transitions (EMT) have been suggested to be crucial during epithelial cancer cell invasion. However, in a three-dimensional organotypic invasion assay squamous cell carcinoma (SCC) cells that retain epithelial characteristics hitch a ride with carcinoma associated fibroblasts (CAFs) in order to collectively invade. Thus epithelial cancer cells can utilise the mesenchymal characteristics of CAFs without the need to undergo EMT themselves. This work provides new insight in cancer cell invasion and shows a new role for CAFs as a target for an anti-invasive therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

Fibroblast activation in cancer: when seed fertilizes soil

Sanya-Eduarda Kuzet, Cedric Gaggioli

CELL AND TISSUE RESEARCH (2016)

Article Oncology

Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts

Stephanie Bonan, Jean Albrengues, Eloise Grasset, Sanya-Eduarda Kuzet, Nicolas Nottet, Isabelle Bourget, Thomas Bertero, Bernard Mari, Guerrino Meneguzzi, Cedric Gaggioli

ONCOTARGET (2017)

Article Oncology

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells

Eloise M. Grasset, Thomas Bertero, Alexandre Bozec, Jonas Friard, Isabelle Bourget, Sabrina Pisano, Margaux Lecacheur, Majdi Maiel, Caroline Bailleux, Alexander Emelyanov, Marius Ilie, Paul Hofman, Guerrino Meneguzzi, Christophe Duranton, Dmitry V. Bulavin, Cedric Gaggioli

CANCER RESEARCH (2018)

Article Biochemical Research Methods

Three-Dimensional Cell Culture Conditions Affect the Proteome of Cancer-Associated Fibroblasts

Regine C. Toelle, Cedric Gaggioli, Joern Dengjel

JOURNAL OF PROTEOME RESEARCH (2018)

Article Cell Biology

Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy

Thomas Bertero, William M. Oldham, Eloise M. Grasset, Isabelle Bourget, Etienne Boulter, Sabrina Pisano, Paul Hofman, Floriant Bellvert, Guerrino Meneguzzi, Dmitry Bulavin, Soline Estrach, Chloe C. Feral, Stephen Y. Chan, Alexandre Bozec, Cedric Gaggioli

CELL METABOLISM (2019)

Article Biochemistry & Molecular Biology

UBTD1 is a mechano-regulator controlling cancer aggressiveness

Stephanie Torrino, Francois-Rene Roustan, Lisa Kaminski, Thomas Bertero, Sabrina Pisano, Damien Ambrosetti, Maeva Dufies, Jay P. Uhler, Emmanuel Lemichez, Amel Mettouchi, Maeva Gesson, Kathiane Laurent, Cedric Gaggioli, Jean-Francois Michiels, Christophe Lamaze, Frederic Bost, Stephan Clavel

EMBO REPORTS (2019)

Letter Dermatology

STAT3 targeting in dystrophic epidermolysis bullosa

V. R. Mittapalli, T. Kuehl, S. E. Kuzet, C. Gretzmeier, D. Kiritsi, C. Gaggioli, L. Bruckner-Tuderman, A. Nystroem

BRITISH JOURNAL OF DERMATOLOGY (2020)

Article Oncology

A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma

Christophe A. Girard, Margaux Lecacheur, Rania Ben Jouira, Ilona Berestjuk, Serena Diazzi, Virginie Prod'homme, Aude Mallavialle, Frederic Larbret, Maeva Gesson, Sebastien Schaub, Sabrina Pisano, Stephane Audebert, Bernard Mari, Cedric Gaggioli, Eleonora Leucci, Jean-Christophe Marine, Marcel Deckert, Sophie Tartare-Deckert

CANCER RESEARCH (2020)

Article Oncology

A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth

Mounir El Mai, Serena Janho dit Hreich, Cedric Gaggioli, Armelle Roisin, Nicole Wagner, Jing Ye, Pierre Jalinot, Julien Cherfils-Vicini, Eric Gilson

Summary: TRF2, upregulated in human cancers, plays a crucial role in both telomere protection and extrinsic effects like angiogenesis and immunosuppression. Two compounds identified through a cell-based screening method, AR-A014418 and alexidine center dot 2HCl, were found to inhibit TRF2's pro-oncogenic properties in vivo. This highlights the potential therapeutic strategy of targeting TRF2 in aggressive tumors.

CANCERS (2021)

Article Medicine, Research & Experimental

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma

Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod'homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frederic Larbret, Sabrina Pisano, Stephane Audebert, Thierry Passeron, Cedric Gaggioli, Christophe A. Girard, Marcel Deckert, Sophie Tartare-Deckert

Summary: The study reveals that physical and structural signals from fibroblast-derived ECM can cause the antiproliferative responses to BRAF/MEK inhibitors to fail in melanoma. Drug-induced linear clustering of DDR1 and DDR2 mediates ECM-mediated drug resistance. Targeting DDR1 and DDR2 can overcome resistance to BRAF-targeted therapy mediated by ECM.

EMBO MOLECULAR MEDICINE (2022)

Article Oncology

Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells

Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur, Cassandre Tavernier, Serena Diazzi, Sabrina Pisano, Marie Irondelle, Aude Mallavialle, Jean Albrengues, Cedric Gaggioli, Christophe A. Girard, Thierry Passeron, Marcel Deckert, Sophie Tartare-Deckert, Virginie Prod'homme

Summary: This study found that dedifferentiated melanoma cells have different effects on the contractile properties of lymph node fibroblasts compared to melanocytic cells. Factors secreted by dedifferentiated cells strongly inhibit the contractile forces of fibroblasts, while those secreted by melanocytic cells do not. Furthermore, dedifferentiated melanoma cells also modulate the biomechanical properties of lymph nodes, promoting tumor invasion.

CANCER RESEARCH (2022)

Article Surgery

Mesenchymal Stem Cells and PRP Therapy Favorize Leak Closure After Sleeve Gastrectomy in Zucker Rats

Marine Benois, Enora Lecorgne, Radwan Kassir, Marjorie Piche, Virginie Ben Amor, Hichem Chenaitia, Jocelyn Gal, Taycir Skhiri, Jean Gugenheim, Cedric Gaggioli, Imed Ben Amor

Summary: This study aimed to investigate the effects of locally administered MSCs and PRP on leak closure following sleeve gastrectomy (SG) in rats. Anatomopathological examination indicated that the closure of the leak orifice was faster in the experimental group, with significantly increased mucosae renewal and fibrosis score. These findings suggest that PRP and MSCs may accelerate the closure of leaks following SG in rats and could potentially be a new treatment for human gastric leaks.

OBESITY SURGERY (2022)

Article Oncology

Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-? activation

Alexandra Mousset, Enora Lecorgne, Isabelle Bourget, Pascal Lopez, Kitti Jenovai, Julien Cherfils-Vicini, Chloe Dominici, Geraldine Rios, Cedric Girard-Riboulleau, Bodu Liu, David L. Spector, Sidse Ehmsen, Shufang Renault, Caroline Hego, Fatima Mechta-Grigoriou, Francois-Clement Bidard, Mikkel Green Terp, Mikala Egeblad, Cedric Gaggioli, Jean Albrengues

Summary: Metastasis is a major cause of cancer death, often accompanied by therapy resistance. In this study, we discovered that chemotherapy induces neutrophil recruitment and NET formation, leading to reduced therapy response in breast cancer lung metastasis mouse models. We further elucidate that chemotherapy-treated cancer cells secrete IL-1(3, which triggers NET formation. NET-associated proteins, integrin-αv(β3 and matrix metalloproteinase 9, play crucial roles in activating latent TGF-β3 and promoting chemoresistance. Our findings suggest that targeting the IL-1(3-NET-TGF-β3 axis could potentially reduce or prevent chemoresistance in the metastatic setting.

CANCER CELL (2023)

Article Clinical Neurology

Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model

Neringa Jurkute, Michele Bertacchi, Gavin Arno, Chiara Tocco, Ungsoo Samuel Kim, Adam M. Kruszewski, Robert A. Avery, Emma C. Bedoukian, Jinu Han, Sung Jun Ahn, Nikolas Pontikos, James Acheson, Indran Davagnanam, Richard Bowman, Marios Kaliakatsos, Alice Gardham, Emma Wakeling, Ngozi Oluonye, Maddy Ashwin Reddy, Elaine Clark, Elisabeth Rosser, Patrizia Amati-Bonneau, Majida Charif, Guy Lenaers, Isabelle Meunier, Sabine Defoort, Catherine Vincent-Delorme, Anthony G. Robson, Graham E. Holder, Luc Jeanjean, Antonio Martinez-Monseny, Mariona Vidal-Santacana, Chloe Dominici, Cedric Gaggioli, Nadia Giordano, Matteo Caleo, Grant T. Liu, Andrew R. Webster, Michele Studer, Patrick Yu-Wai-Man

Summary: Pathogenic NR2F1 variants cause a rare autosomal dominant neurodevelopmental disorder, contributing to visual impairment due to abnormal retinal and optic nerve head development. The study suggests NR2F1 as a major gene orchestrating early retinal and optic nerve head development, playing a key role in the maturation of the visual system.

BRAIN COMMUNICATIONS (2021)

Article Oncology

Mechanical forces rewire metabolism in the tumor niche

Thomas Bertero, Cedric Gaggioli

MOLECULAR & CELLULAR ONCOLOGY (2019)

暂无数据